The Role of Cancer Stem Cells in Tumor Radioresistance

Cancer Stem Cells

Volumn , Issue , 2014, Pages 473-491

  Kurth, I ^a   Peitzsch, C ^a   Baumann, M ^a   Dubrovska, A ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cancer stem cells (CSCs); Cancer treatment; Tumor radioresistance

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; DISEASES; RADIOTHERAPY; STEM CELLS;

CANCER STEM CELL; CANCER STEM CELLS; CELL POPULATIONS; CELLULAR ADAPTATION; LOCAL TUMOR CONTROL; MICROENVIRONMENTAL FACTORS; RADIORESISTANCE; SMALL CELLS; TUMOR MASS; TUMOR RADIORESISTANCE;

TUMORS;

EID: 84923256484     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118356203.ch35     Document Type: Chapter

References (113)

1. Al-Assar, O., Mantoni, T., Lunardi, S., Kingham, G., Helleday, T., Brunner, T.B. (2011). Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fraction. Cancer Biol Ther. 11(12):1028-1035.
2. Allalunis-Turner, M.J., Barron, G.M., Day, R.S. 3rd, Fulton, D.S., Urtasun, R.C. (1992). Radiosensitivity testing of human primary brain tumor specimens. Int J Radiat Oncol Biol Phys. 23(2):339-343.
3. Anderson, P., Dische, S. (1981). Local tumor control and the subsequent incidence of distant metastatic disease. Int J Radiat Oncol Biol Phys. 7(12):1645-1648.
4. Ansiaux, R., Baudelet, C., Jordan, B.F., Beghein, N., Sonveaux, P., De Wever, J., Martinive, P., Grégoire, V., Feron, O., Gallez, B. (2005). Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res. 11(2 Pt 1):743-750.
5. Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Bigner, D.D., Rich, J.N. (2006). Glioma stem cells promoteradioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760.
6. Baumann, M., Dubois, W., Suit, H.D. (1990). Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiationsensitivity in vivo, and tumor rescuing units. Radiat Res. 123(3):325-330.
7. Baumann, M., Dörr, W., Petersen, C., Krause, M. (2003). Repopulation during fractionated radiotherapy: much has been learned, even more is open. Int J Radiat Biol. 79(7):465-467.
8. Bauman, M., Gregoire, V. (2009). "Modified fractionation." In: Joiner, M., van der Kogel, A. (Eds.): Basic Clinical Radiobiology, pp. 135-148. London, United Kingdom, Arnold.
9. Baumann, M., Krause, M., Hill, R. (2008). Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 8(7):545-554.
10. Baumann, M., Krause, M., Thames, H., Trott, K., Zips, D. (2009). Cancer stem cells and radiotherapy. Int J Radiat Biol. 85(5):391-402.
11. Baumann, M., Krause, M. (2010). CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res. 16(21):5091-5093.
12. Baumann, M., Herrmann, T., Koch, R., Matthiessen, W., Appold, S., Wahlers, B., Kepka, L., Marschke, G., Feltl, D., Fietkau, R., Budach, V., Dunst, J., Dziadziuszko, R., Krause, M., Zips, D.; CHARTWEL-Bronchus study group. (2011). Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC). Radiother Oncol. 100(1):76-85.
13. Begg, A.C., Stewart, F.A., Vens, C. (2011). Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 11(4):239-253.
14. Bentzen, S.M., Thames, H.D. (1996). Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys. 36(1):247-251.
15. Bentzen, S.M., Baumann, M. (2002). "The linear-quadratic model in clinical practice". In: Steel GG (Ed.): Basic Clinical Radiobiology, pp. 134-146. London, United Kingdom, Arnold.
16. Bourhis, J., Overgaard, J., Audry, H., Ang, K.K., Saunders, M., Bernier, J., Horiot, J.C., Le Maître, A., Pajak, T.F., Poulsen, M.G., O'Sullivan, B., Dobrowsky, W., Hliniak, A., Skladowski, K., Hay, J.H., Pinto, L.H., Fallai, C., Fu, K.K., Sylvester, R., Pignon, J.P. (2006). Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 368(9538):843-854.
17. Borovski, T., De Sousa, E., Melo, F., Vermeulen, L., Medema, J.P. (2011). Cancer stem cell niche: the place to be. Cancer Res. 71(3):634-639.
18. Brock, W.A., Baker, F.L., Wike, J.L., Sivon, S.L., Peters, L.J. (1990). Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys. 18(6):1283-1286.
19. Brunner, T.B., Kunz-Schughart, L.A., Grosse-Gehling, P., Baumann, M. (2012). Cancer stem cells as a predictive factor in radiotherapy. Semin Radiat Oncol. 22(2):151-174.
20. Chung, Y.L., Jian, J.J., Cheng, S.H., Tsai, S.Y., Chuang, V.P., Soong, T., Lin, Y.M., Horng, C.F. (2006). Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clin Cancer Res. 12(9):2706-2715.
21. Cook, J.A., Gius, D., Wink, D.A., Krishna, M.C., Russo, A., Mitchell, J.B. (2004). Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol. 14(3):259-266.
22. Diehn, M., Cho, R.W., Lobo, N.A., Kalisky, T., Dorie, M.J., Kulp, A.N., Qian, D., Lam, J.S., Ailles, L.E., Wong, M., Joshua, B., Kaplan, M.J., Wapnir, I., Dirbas, F.M., Somlo, G., Garberoglio, C., Paz, B., Shen, J., Lau, S.K., Quake, S.R., Brown, J.M., Weissman, I.L., Clarke, M.F. (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 58 (7239):780-783.
23. Dische, S., Saunders, M., Barrett, A., Harvey, A., Gibson, D., Parmar, M. (1997). A randomisedmulticentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44(2):123-136.
24. Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J., Wicha, M.S. (2003). In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17(10):1253-1270.
25. Dubben, H.H., Thames, H.D., Beck-Bornholdt, H.P. (1998). Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol. 47(2):167-174.
26. Eke, I., Cordes, N. (2011). Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation. Radiother Oncol. 99(3):271-278.
27. Eschmann, S.M., Paulsen, F., Reimold, M., Dittmann, H., Welz, S., Reischl, G., Machulla, H.J., Bares, R. (2005). Prognostic impact of hypoxia imaging with 18 F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46(2):253-260.
28. Eschwege, F., Bourhis, J., Girinski, T., Lartigau, E., Guichard, M., Deblé, D., Kepta, L., Wilson, G.D., Luboinski, B. (1997). Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. Int J Radiat Oncol Biol Phys. 39(4):849-853.
29. Fagundes, H., Perez, C.A., Grigsby, P.W., Lockett, M.A. (1992). Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 24(2):197-204.
30. Friedrich, J., Ebner, R., Kunz-Schughart LA. (2007). Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge? Int J Radiat Biol. 83(11-12):849-871.
31. Fu, K.K., Pajak, T.F., Trotti, A., Jones, C.U., Spencer, S.A., Phillips, T.L., Garden, A.S., Ridge, J.A., Cooper, J.S., Ang, K.K. (2000). A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 48(1):7-16.
32. Fuks, Z., Leibel, S.A., Wallner, K.E., Begg, C.B., Fair, W.R., Anderson, L.L., Hilaris, B.S., Whitmore, W.F. (1991). The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys. 21(3):537-547.
33. van Gent, D.C., Hoeijmakers, J.H., Kanaar, R. (2001). Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2:196-206.
34. Gerweck, L.E., Zaidi, S.T., Zietman, A. (1994). Multivariate determinants of radiocurability. I: Prediction of single fraction tumor control doses. Int J Radiat Oncol Biol 30;29(1):57-66.
35. Girinsky, T., Lubin, R., Pignon, J.P., Chavaudra, N., Gazeau, J., Dubray, B., Cosset, J.M., Socie, G., Fertil, B. (1993). Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 25(1):3-7.
36. Grosse-Gehling, P., Fargeas, C.A., Dittfeld, C., Garbe, Y., Alison, M.R., Corbeil, D., Kunz-Schughart, L.A. (2012). CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. doi: 10.1002/path.4086.
37. Harada, H. (2011). How can we overcome tumor hypoxia in radiation therapy? J Radiat Res. 52(5):545-556.
38. Heddleston, J.M., Li, Z., McLendon, R.E., Hjelmeland, A.B., Rich, J.N. (2009). The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle. 8(20):3274-3284.
39. Hittelman, W.N., Liao, Y., Wang, L., Milas, L. (2010). Are cancer stem cells radioresistant? Future Oncol. 6(10):1563-1576.
40. Hill, R.P., Marie-Egyptienne, D.T., Hedley, D.W. (2009). Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol. 19(2):106-111.
41. Hill, R.P., Milas, L. (1989). The proportion of stem cells in murine tumors. Int J Radiat Oncol Biol Phys.16(2):513-518.
42. Ishikawa, T., Nakashiro, K., Klosek, S.K., Goda, H., Hara, S., Uchida, D., Hamakawa, H. (2009). Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep. 21(3):707-712.
43. Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., Masuko, T., Shimizu, T., Ishikawa, T., Kai, K., Takahashi, E., Imamura, Y., Baba, Y., Ohmura, M., Suematsu, M., Baba, H., Saya, H. (2011). CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19(3):387-400.
44. Jacobson, O., Weiss, I.D., Szajek, L.P., Niu, G., Ma, Y., Kiesewetter, D.O., Farber, J.M., Chen X. (2011). PET imaging of CXCR4 using copper-64 labeled peptide antagonist. Theranostics 1:251-262.
45. Jeggo, P.A., Löbrich, M. (2006). Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability. DNA Repair (Amst). 5(9-10):1192-1198.
46. Jeter, C.R., Liu, B., Liu, X., Chen, X., Liu, C., Calhoun-Davis, T., Repass, J., Zaehres, H., Shen, J.J., Tang, D.G. (2011). NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30(36):3833-3845.
47. Johnson, C.R., Thames, H.D., Huang, D.T., Schmidt-Ullrich, R.K. (1995). The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys. 33(2):281-287.
48. de Jong, M.C., Pramana, J., van der Wal, J.E., Lacko, M., Peutz-Kootstra, C.J., de Jong, J.M., Takes, R.P., Kaanders, J.H., van der Laan, B.F., Wachters, J., Jansen, J.C., Rasch, C.R., van Velthuysen, M.L., Grénman, R., Hoebers, F.J., Schuuring, E., van den Brekel, M.W., Begg, A.C. (2010). CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res. 16(21):5329-5338.
49. Karran, P. DNA double strand break repair in mammalian cells. (2000). Curr Opin Genet Dev. 10:144-150.
50. Kasten-Pisula, U., Tastan, H., Dikomey, E. (2005). Huge differences in cellular radiosensitivity due to only very small variations in double-strand break repair capacity. Int J Radiat Biol. 81(6):409-419.
51. Kim, J.I., Tannock, I.F. (2005). Repopulation of cancer cells during therapy: an important cause of treatment failure. Nature Reviews Cancer 5(7):516-525.
52. Koch, U., Krause, M., Baumann, M. (2010). Cancer stem cells at the crossroads of current cancer therapy failures-radiation oncology perspective. Semin Cancer Biol. 20(2):116-124.
53. Kokko, L.L., Hurme, S., Maula, S.M., Alanen, K., Grénman, R., Kinnunen, I., Ventelä, S. (2011). Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol. 47(6):510-516.
54. Koukourakis, M.I., Giatromanolaki, A., Tsakmaki, V., Danielidis, V., Sivridis, E. (2012). Cancer stem cell phenotype relates to radiochemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer 106(5):846-853.
55. Kuonen, F., Secondini, C., Ruegg, C. (2012). Molecular Pathways: Emerging pathways mediating growth, invasion and metastasis of tumors progressing in an irradiated microenvironment. Clin Cancer Res. PMID 22730447.
56. Kwon, G.Y., Ha, H., Ahn, G., Park, S.Y., Huh, S.J., Park, W. (2007). Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 69(4):1150-1156.
57. Lander, A.D., Kimble, J., Clevers, H., Fuchs, E., Montarras, D., Buckingham, M., Calof, A.L., Trumpp, A., Oskarsson, T. (2012). What does the concept of the stem cell niche really mean today? BMC Biol. 10:19.
58. Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R.E., Hjelmeland, A.B., Rich, J.N. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15(6):501-513.
59. Li, Z., Rich, J.N. (2010). Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol. 345:21-30.
60. Linkous, A.G., Yazlovitskaya, E.M. (2012). Novel radiosensitizing anticancer therapeutics. Anticancer Res. 32(7):2487-2499.
61. Lisanti, M.P., Martinez-Outschoorn, U.E., Chiavarina, B., Pavlides, S., Whitaker-Menezes, D., Tsirigos, A., Witkiewicz, A., Lin, Z., Balliet, R., Howell, A., Sotgia, F. (2010). Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biol Ther. 10(6):537-542.
62. Lomonaco, S.L., Finniss, S., Xiang, C., Decarvalho, A., Umansky, F., Kalkanis, S.N., Mikkelsen, T., Brodie, C. (2009). The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer. 125(3):717-722.
63. Martelli, A.M., Evangelisti, C., Follo, M.Y., Ramazzotti, G., Fini, M., Giardino, R., Manzoli, L., McCubrey, J.A., Cocco, L. (2011). Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network incancer stem cells. Curr Med Chem. 18(18):2715-2726.
64. Mauguen, A., Le Péchoux, C., Saunders, M.I., Schild, S.E., Turrisi, A.T., Baumann, M., Sause, W.T., Ball, D., Belani, C.P., Bonner, J.A., Zajusz, A., Dahlberg, S.E., Nankivell, M., Mandrekar, S.J., Paulus, R., Behrendt, K., Koch, R., Bishop, J.F., Dische, S., Arriagada, R., De Ruysscher, D., Pignon, J.P. (2012). Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol. 30(22):2788-2797.
65. Medema, J.P., Vermeulen, L. (2011). Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature. 474(7351): 318-326.
66. Metellus, P., Nanni-Metellus, I., Delfino, C., Colin, C., Tchogandjian, A., Coulibaly, B., Fina, F., Loundou, A., Barrie, M., Chinot, O., Ouafik, L., Figarella-Branger, D. (2011). Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Ann Surg Oncol. (10):2937-2945.
67. Mikkelsen, R.B., Wardman, P.(2003). Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene. 22(37):5734-5754.
68. Mladenov, E., Iliakis, G. (2011). Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways. Mutat Res. 711(1-2):61-72.
69. Mohyeldin, A., Garzón-Muvdi, T., Quiñones-Hinojosa, A. (2010). Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7(2):150-161.
70. Nguyen, D.H., Oketch-Rabah, H.A., Illa-Bochaca, I., Geyer, F.C., Reis-Filho, J.S., Mao, J.H., Ravani, S.A., Zavadil, J., Borowsky, A.D., Jerry, D.J., Dunphy, K.A., Seo, J.H., Haslam, S., Medina, D., Barcellos-Hoff, M.H. (2011). Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell. 19(5):640-651.
71. Overgaard, J. (2007). Hypoxic radiosensitization: adored and ignored. J Clin Oncol. 25(26): 4066-4074.
72. Overgaard, J. (2011). Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck-a systematicreview and meta-analysis. Radiother Oncol. 100(1):22-32.
73. Pajonk, F., Vlashi, E., McBride, W.H. (2010). Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells. 28(4): 639-648.
74. Pallini, R., Ricci-Vitiani, L., Banna, G.L., Signore, M., Lombardi, D., Todaro, M., Stassi, G., Martini, M., Maira, G., Larocca, L.M., De Maria, R. (2008). Cancer stem cell analysis and clinical outcome in patients with glioblastomamultiforme. Clin. Cancer Res. 14(24):8205-8212.
75. Petersen, C., Zips, D., Krause, M., Schöne, K., Eicheler, W., Hoinkis, C., Thames, H.D., Baumann, M. (2001). Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys. 51(2):483-493.
76. Phillips, T.M., McBride, W.H., Pajonk, F. (2006). The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777-1785.
77. Pietras, A., Hansford, L.M., Johnsson, A.S., Bridges, E., Sjölund, J., Gisselsson, D., Rehn, M., Beckman, S., Noguera, R., Navarro, S., Cammenga, J., Fredlund, E., Kaplan, D.R., Påhlman, S. (2009). HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc Natl Acad Sci USA. 106(39):16805-16810.
78. Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M.A., Daidone, M.G. (2005). Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65(13):5506-5511.
79. Prestegarden, L., Enger, P. ø. (2010). Cancer stem cells in the central nervous system-a critical review. Cancer Res. 70(21):8255-8258.
80. Reynolds, B.A., Weiss, S. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 255(5052):1707-1710.
81. Ross, G.M. (1999). Induction of cell death by radiotherapy. Endocr Relat Cancer. 6(1):41-44.
82. Saigusa, S., Tanaka, K., Toiyama, Y., Yokoe, T., Okugawa, Y., Ioue, Y., Miki, C., Kusunoki, M. (2009). Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol. 16(12):3488-3498.
83. Schwartz, J.D., Rowinsky, E.K., Youssoufian, H., Pytowski, B., Wu, Y. (2010). Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18 F1 (Human antibody targeting vascular endothelial growth factor receptor-1). Cancer. 15;116(4 Suppl):1027-1032.
84. Schwarz, G. (1909). Ueber Desensibilisierung gegen Roentgen- und Radiumstrahlen. Muenchner Medizinische Wochenschrift. 56:1217-1218.
85. Seymour, C.B., Mothersill, C., Alper, T. (1986). High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. Int J Radiat Biol Relat Stud Phys Chem Med. Jul;50(1):167-179.
86. Shigdar, S., Lin, J., Li, Y., Yang, C.J., Wei, M., Zhus, Y., Liu, H., Duan, W. (2012). Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging. Ther Deliv. 3(2):227-244.
87. Situ, D., Long, H., Lin, P., Zhu, Z., Wang, J., Zhang, X., Xie, Z., Rong, T. (2010). Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma. J Cancer Res Clin Oncol. 136(8):1213-1219.
88. Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R.D., Engh, J., Iwama, T., Kunisada, T., Kassam, A.B., Pollack, I.F., Park, D.M. (2009). Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene. 28(45):3949-3959.
89. Suit, H.D., Shalek, R.J., Wette, R. (1965). Radiation response of C3H mouse mammary carcinoma evaluated in terms of cellular radiation sensitivity. In: Cellular radiation biology. Baltimore: Williams and Wilkins; 514-530.
90. Sofia Vala, I., Martins, L.R., Imaizumi, N., Nunes, R.J., Rino, J., Kuonen, F., Carvalho, L.M., Rüegg, C., Grillo, I.M., Barata, J.T., Mareel, M., Santos, S.C. (2010). Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One 2010;5: e11222.
91. Sutherland, R.M., Inch, W.R., McCredie, J.A., Kruuv, J. (1970). A multi-component radiation survival curve using an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med. 18(5):491-495.
92. Stausbøl-Grøn, B., Overgaard, J. (1999). Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck. Radiother Oncol. 50(1):47-55.
93. Sutherland, R.M., McCredie, J.A., Inch, W.R. (1971). Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. Journal of the National Cancer Institute 46(1):113-120.
94. Suwinski, R., Taylor, J.M., Withers, H.R. (1998). Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):943-951.
95. Taghian, A., DuBois, W., Budach, W., Baumann, M., Freeman, J., Suit, H. (1995). In vivo radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 32(1):99-104.
96. Tao, Y., Daly-Schveitzer, N., Lusinchi, A., Bourhis, J. (2010). Advances in radiotherapy of head and neck cancers. Curr Opin Oncol. 22(3):194-199.
97. Thompson, L.H., Schild, D. (2001). Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res. 477:131-153.
98. Tsurumi, C., Esser, N., Firat, E., Gaedicke, S., Follo, M., Behe, M., Elsässer-Beile, U., Grosu, A.L., Graeser, R., Niedermann, G. (2010). Noninvasive in vivo imaging of tumor- associated CD133/prominin. PLoS One. 5(12):e15605.
99. Wang, J., Sullenger, B.A., Rich, J.N. (2012). Notch signaling in cancer stem cells. Adv Exp Med Biol. 727:174-185.
100. Wang, J., Wakeman, T.P., Lathia, J.D., Hjelmeland, A.B., Wang, X.F., White, R.R., Rich, J.N., Sullenger, B.A. (2010). Notch promotes radioresistance of glioma stem cells. Stem Cells. 28(1):17-28.
101. Weichselbaum, R.R., Dahlberg, W., Little, J.B. (1985). Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA. 82(14):4732-4735.
102. West, C.M., Davidson, S.E., Roberts, S.A., Hunter, R.D. (1993). Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 68(4):819-823.
103. Withers, H.R. (1975). The four R's of radiotherapy. New York: Academic Press. Lett JTAH, editor. Advances in radiation biology. 5.
104. Woodward, W.A., Chen, M.S., Behbod, F., Alfaro, M.P., Buchholz, T.A., Rosen, J.M. (2007). WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA. 104(2):618-623.
105. Yamada, K.M., Cukierman, E. (2007). Modeling tissue morphogenesis and cancer in 3D. Cell 130(4):601-610.
106. Yaromina, A., Krause, M., Thames, H., Rosner, A., Krause, M., Hessel, F., Grenman, R., Zips, D., Baumann, M. (2007). Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol. 83(3):304-310.
107. Yaromina, A., Kroeber, T., Meinzer, A., Boeke, S., Thames, H., Baumann, M., Zips, D. (2011). Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts. Int J Radiat Oncol Biol Phys. 80(4):1205-1213.
108. Yin, H., Glass, J. (2011). The Phenotypic Radiation Resistance of CD44+/CD24-or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling. PLoS One. 6(9): e24080.
109. Zagzag, D., Lukyanov, Y., Lan, L., Ali, M.A., Esencay, M., Mendez, O., Yee, H., Voura, E.B., Newcomb, E.W. (2006). Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest. 86(12): 1221-1232.
110. Zhang, M., Behbod, F., Atkinson, R.L., Landis, M.D., Kittrell, F., Edwards, D., Medina, D., Tsimelzon, A., Hilsenbeck, S., Green, J.E., Michalowska, A.M., Rosen, J.M. (2008). Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 68(12):4674-4682.
111. Zhang, X.P., Zheng, G., Zou, L., Liu, H.L., Hou, L.H., Zhou, P., Yin, D.D., Zheng, Q.J., Liang, L., Zhang, S.Z., Feng, L., Yao, L.B., Yang, A.G., Han, H., Chen, J.Y. (2008). Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem. 307(1-2):101-108.
112. Zhang, M., Atkinson, R.L., Rosen, J.M. (2010). Selective targeting of radiation-resistant tumor-initiating cells. Proc Natl Acad Sci USA 107:3522-3527.
113. Zips, D., Böke, S., Kroeber, T., Meinzer, A., Brüchner, K., Thames, H.D., Baumann, M., Yaromina, A. (2011). Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control. Strahlenther Onkol. 187(5):306-310.